Certain Ordinary Shares of Eucrates Biomedical Acquisition Corp. are subject to a Lock-Up Agreement Ending on 22-APR-2021. These Ordinary Shares will be under lockup for 181 days starting from 23-OCT-2020 to 22-APR-2021.

Details:
The executive officers, directors, and all of the holders of equity securities have entered into a lock up agreement pursuant to which, they will not to offer, sell, contract to sell, pledge, or otherwise dispose of, directly or indirectly, or hedge units, warrants, shares of common stock or any other securities convertible into or exchangeable or exercisable for common stock for a period of 180 days after the date of the final prospectus, without the prior written consent of Stifel, Nicolaus & Company, Incorporated and H.C. Wainwright & Co., LLC, on behalf of the underwriters.